Ep. 107 - A Tale of Two Targets: LAG3, IL-2; Plus Alternatives to Cash Up
BioCentury This Week
00:00
What Are Companies Doing to Make It Through These Tough Times?
Last year we saw billions and billions of dollars in fund raises by a follow on financ tings. This year, not so much. What are companies doing to make it through these tough times?
Transcript
Play full episode
